| Original language | English |
|---|---|
| Pages (from-to) | 1684-1735 |
| Number of pages | 52 |
| Journal | The Lancet |
| Volume | 392 |
| Issue number | 10159 |
| DOIs | |
| Publication status | Published (VoR) - 10 Nov 2018 |
Funding
Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St. Jude Children's Research Hospital, the National Institute on Aging of the National Institutes of Health (award P30AG047845) , and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. Data for this research was provided by MEASURE Evaluation, funded by the United States Agency for International Development (USAID). Views expressed do not necessarily reflect those of USAID, the US Government, or MEASURE Evaluation. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with licence no. SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law—2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. Yannick Bejot reports grants and personal fees from AstraZeneca and Boehringer Ingelheim and personal fees from Daiichi-Sankyo, BMS, Pfizer, Medtronic, Bayer, Novex Pharma, and MSD. Adam Berman reports personal fees from Philips. Cyrus Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB. Mir Sohail Fazeli reports personal fees from Doctor Evidence LLC. Bradford Gessner reports other income from Pfizer Vaccines. Panniyammakal Jeemon reports a Clinical and Public Health Intermediate Fellowship from the Wellcome Trust-DBT India Alliance (2015–2020). Jacek Jóźwiak reports a grant and personal fees from Valeant, personal fees from ALAB Laboratoria and Amgen, and non-financial support from Microlife and Servier. Nicholas Kassebaum reports personal fees and other from Vifor Pharmaceuticals, LLC. Srinivasa Vittal Katikireddi reports grants from NHS Research Scotland (SCAF/15/02), Medical Research Council (MC_UU_12017/13 and MC_UU_12017/15), and Scottish Government Chief Scientist Office (SPHSU13 and SPHSU15). Pablo Lavados reports grants from Bayer AG, PHRI, The George Institute for Global Health, Conicyt Fonis, and Clinica Alemania; non-financial support from Boehringer Ingelheim; grant support for RECCA registry and travel expenses for Nandu Proyect, and other support from EVERpharma. Jeffrey Lazarus reports personal fees from Janssen and CEPHEID and grants and personal fees from AbbVie, Gilead Sciences, and MSD. Winfried März reports grants and personal fees from Siemens Diagnostics, Aegerion Pharmaceuticals, Amgen, AstraZeneca, Danone Research, Pfizer, BASF, Numares AG, and Berline-Chemie; personal fees from Hoffmann LaRoche, MSD, Sanofi, and Synageva; grants from Abbott Diagnostics; and other from Synlab Holding Deutschland GmbH. Walter Mendoza is currently a Program Analyst for Population and Development at the Peru Country Office of the United Nations Population Fund (UNFPA) which does not necessarily endorse this study. Bo Norrving reports personal fees from AstraZeneca and Bayer. Constance Dimity Pond reports personal fees from Nutricia advisory board, acted as an unpaid consultant to the Wicking Dementia Research and Education Centre in Tasmania for development of general practitioner education on dementia (airfares and accommodation paid), was paid as a dementia clinical lead and dementia pathways adviser for the Sydney North Primary Health Network, and paid as a GP educator for Presbyterian Aged Care. Maarten Postma reports grants from Mundipharma, Bayer, BMS, AstraZeneca, ARTEG, and AscA; grants and personal fees from Sigma Tau, MSD, GlaxoSmithKline, Pfizer, Boehringer Ingelheim, Novavax, Ingress Health, AbbVie, and Sanofi; personal fees from Quintiles, Astellas, Mapi, OptumInsight, Novartis, Swedish Orphan, Innoval, Jansen, Intercept, and Pharmerit, and stock ownership in Ingress Health and Pharmacoeconomics Advice Groningen (PAG Ltd). Kazem Rahimi reports grants from NIHR BRC, ESRC, and Oxford Martin School. Miloje Savic is employed by GlaxoSmithKline Biologicals, S.A, Belgium. Kenji Shibuya reports grants from Ministry of Health, Labour, and Welfare and from Ministry of Education, Culture, Sports, Science, and Technology. Mark Shrime reports grants from Mercy Ships and Damon Runyon Cancer Research Foundation. Jasvinder Singh reports consulting for Horizon, Fidia, UBM LLC, Medscape, WebMD, the National Institutes of Health, and the American College of Rheumatology; they serve as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, Inc., a 501c3 entity; they are on the steering committee of OMERACT, an international organisation that develops measures for clinical trials and receives arms-length funding from 36 pharmaceutical companies. Cassandra Szoeke reports a grant from the National Medical Health Research Council, Lundbeck, Alzheimer's Association, and the Royal Australasian College of Practicioners; she holds patent PCT/AU2008/001556. Amanda Thrift reports grants from National Health and Medical Research Council, Australia. Muthiah Vaduganathan receives research support from the NIH/NHLBI and serves as a consultant for Bayer AG and Baxter Healthcare. Marcel Yotebieng reports grants from the US National Institutes of Health. All other authors declare no competing interests.
Fingerprint
Dive into the research topics of 'Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver